TrialMedical oncology (Northwood, London, England)2015

Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation.

Hua Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.